UBS AM Portfolio holdings
UBS AM is the US asset manager of UBS and grew out of Brinson Partners, an investment firm founded by Gary Brinson and made independent in 1989. Swiss Bank Corporation bought Brinson Partners in 1994, and once the bank merged with UBS, its founder Gary Brinson, who had run Swiss Bank's asset management business, became chief investment officer of UBS Asset Management. In 2024 the business took in Credit Suisse Asset Management and two of its own units, UBS Hedge Fund Solutions and UBS O’Connor, though the O’Connor business was later sold. Its clients are mainly institutions such as retirement plans, government bodies, endowments and foundations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1501
Delek US
DK
$4.35B
| $5.91M | ﹤0.01% |
116,248
-2,974
| -2% | -$132K |
2013 Q2
52 quarters
|
|
1502
Par Pacific Holdings
PARR
$3.67B
| $5.91M | ﹤0.01% |
105,321
+4,151
| +4% | +$247K |
2015 Q4
42 quarters
|
|
1503
Acadia Pharmaceuticals
ACAD
$3.58B
| $5.9M | ﹤0.01% |
233,329
+26,445
| +13% | +$582K |
2023 Q1
13 quarters
|
|
1504
Navitas Semiconductor
NVTS
$2.42B
| $5.89M | ﹤0.01% |
328,522
-20,273
| -6% | -$387K |
2025 Q3
3 quarters
|
|
1505
JPMorgan BetaBuilders Japan ETF
BBJP
$19.1B
| $5.88M | ﹤0.01% |
78,126
-60,305
| -44% | -$4.45M |
2025 Q4
2 quarters
|
|
1506
Cheesecake Factory
CAKE
$5.63B
| $5.88M | ﹤0.01% |
73,949
-15,128
| -17% | -$980K |
2013 Q2
52 quarters
|
|
1507
Progyny
PGNY
$2.18B
| $5.86M | ﹤0.01% |
203,371
-7,716
| -4% | -$172K |
2023 Q1
13 quarters
|
|
1508
Coastal Financial
CCB
$667M
| $5.85M | ﹤0.01% |
75,499
-193,190
| -72% | -$14.5M |
2024 Q2
8 quarters
|
|
1509
Minerals Technologies
MTX
$1.92B
| $5.85M | ﹤0.01% |
79,069
-5,173
| -6% | -$391K |
2013 Q2
52 quarters
|
|
1510
SPS Commerce
SPSC
$3.09B
| $5.83M | ﹤0.01% |
101,896
+1,008
| +1% | +$55.6K |
2013 Q2
52 quarters
|
|
1511
Alamos Gold
AGI
$12.1B
| $5.8M | ﹤0.01% |
191,073
+29,974
| +19% | +$1.21M |
2024 Q2
8 quarters
|
|
1512
Academy Sports + Outdoors
ASO
$3.72B
| $5.8M | ﹤0.01% |
123,002
+2,930
| +2% | +$156K |
2021 Q2
20 quarters
|
|
1513
Empire State Realty Trust
ESRT
$874M
| $5.78M | ﹤0.01% |
1,067,924
+1,067,101
| +129,660% | +$5.8M |
2013 Q4
50 quarters
|
|
1514
Unifirst Corp
UNF
$4.66B
| $5.78M | ﹤0.01% |
21,845
-3,475
| -14% | -$908K |
2013 Q2
52 quarters
|
|
1515
Pediatrix Medical
MD
$2.37B
| $5.77M | ﹤0.01% |
227,836
-13,592
| -6% | -$309K |
2023 Q1
13 quarters
|
|
1516
Workiva
WK
$4.5B
| $5.72M | ﹤0.01% |
117,899
-9,540
| -7% | -$491K |
2016 Q3
39 quarters
|
|
1517
Agilysys
AGYS
$3.27B
| $5.67M | ﹤0.01% |
54,288
-158
| -0.3% | -$12.2K |
2020 Q4
22 quarters
|
|
1518
DELISTED
DigitalBridge
DBRG
| $5.67M | ﹤0.01% |
359,171
+6,132
| +2% | +$95.9K |
2020 Q1
25 quarters
|
|
1519
Vanguard Real Estate ETF
VNQ
$37.7B
| $5.66M | ﹤0.01% |
58,661
-22,068
| -27% | -$2.11M |
2025 Q4
2 quarters
|
|
1520
Hawkins
HWKN
$3.2B
| $5.65M | ﹤0.01% |
39,730
-6,327
| -14% | -$1M |
2021 Q3
19 quarters
|
|
1521
nLIGHT
LASR
$2.25B
| $5.64M | ﹤0.01% |
80,942
+3,482
| +4% | +$243K |
2025 Q3
3 quarters
|
|
1522
Artisan Partners
APAM
$2.58B
| $5.62M | ﹤0.01% |
162,644
-16,408
| -9% | -$603K |
2014 Q1
49 quarters
|
|
1523
IMAX
IMAX
$2.82B
| $5.61M | ﹤0.01% |
140,838
+138,078
| +5,003% | +$5.29M |
2023 Q1
13 quarters
|
|
1524
Calumet Specialty Products
CLMT
$4.26B
| $5.6M | ﹤0.01% |
155,584
+25,348
| +19% | +$852K |
2024 Q4
6 quarters
|
|
1525
Ultragenyx Pharmaceutical
RARE
$1.65B
| $5.58M | ﹤0.01% |
167,226
-55,822
| -25% | -$1.39M |
2014 Q4
46 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.